journal article·2022-05-19Open access

Ultrastructural Features of Keratoacanthoma—Clinical Implications

Doinița Temelie-Olinici, Petronela Bărgăoanu, Iolanda Foia, Pavel Onofrei, Cristina Daniela Dimitriu, Ana-Emanuela Botez, Laura Stoica, Vasile-Bogdan Grecu, Elena-Carmen Cotrutz

Applied Sciences· Volume 12· Issue 10

Abstract

Over the years, keratoacanthomas have been described as some of the most common skin lesions with the potential for malignant transformation, thus constituting an important risk factor for the development of squamous cell carcinoma. The quantification of the risk of malignant transformation is conditioned by the clinical–morphological and etiopathogenic variability of these lesions, with a negative impact on diagnostic and therapeutic management. In this sense, the main objective of this research is to characterize from an ultrastructural perspective the specific tumour microenvironment, by using a technique with a higher resolution power than photon microscopy. Keratoacanthoma lesions from 25 patients were excised from healthy tissue and then processed by classical electron microscopy and examined with the Philips CM100 microscope. The electron microscopic study revealed structural details suggestive of malignant transformation, capturing changes at both cytoplasmic and membranous levels. The identification and description of the ultrastructural morphological substrate favouring the evolution and progression of the studied lesions correlates directly with the improvement of the prognosis and quality of life of these patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nonmelanoma Skin Cancer Studies · Wound Healing and Treatments · Skin Protection and Aging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Morpho-Functional Sciences II, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iași, Romania

Department of Preventive Medicine and Interdisciplinarity, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iași, Romania

References (25)

Show source-provided references
1. Laikova, K.V., Oberemok, V.V., Krasnodubets, A.M., Gal’chinsky, N.V., Useinov, R.Z., Novikov, I.A., Temirova, Z.Z., Gorlov, M.V., Shved, N.A., and Kumeiko, V.V. (2019). Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules, 24.10.3390/molecules24081516 ↗
2. Vascular structures in dermoscopy10.1590/abd1806-4841.20153452 ↗
3. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia10.1001/jamadermatol.2020.4097 ↗
4. Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma10.3889/oamjms.2018.133 ↗
5. The Effectiveness of Cryosurgery Combined with Curettage and Electrodessication in the Treatment of Keratoacanthoma: A Retrospective Analysis of 90 Cases10.4103/ijd.IJD_202_18 ↗
6. Molecular and cell biology translational researches in the management of oral premalignant lesions
7. Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis10.1159/000493089 ↗
8. Enhancing Skin Cancer Diagnosis with Dermoscopy10.1016/j.det.2017.06.003 ↗
9. Usefulness of Dermoscopy to Provide Accurate Assessment of Skin Cancers10.2147/CCID.S305924 ↗
10. Molecular markers associated with potentially malignant oral lesions (Review)
11. Porumb-Andrese, E., Scutariu, M.M., Luchian, I., Schreiner, T.G., Mârţu, I., Porumb, V., Popa, C.G., Sandu, D., and Ursu, R.G. (2021). Molecular Profile of Skin Cancer. Appl. Sci., 11.10.3390/app11199142 ↗
12. UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes10.1096/fj.202001412R ↗
13. Fania, L., Didona, D., Di Pietro, F.R., Verkhovskaia, S., Morese, R., Paolino, G., Donati, M., Ricci, F., Coco, V., and Ricci, F. (2021). Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 9.10.3390/biomedicines9020171 ↗
14. Keratoacanthoma (KA): An update and review10.1016/j.jaad.2015.11.033 ↗
15. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system10.1016/j.humimm.2017.02.002 ↗
16. Corchado-Cobos, R., García-Sancha, N., González-Sarmiento, R., Pérez-Losada, J., and Cañueto, J. (2020). Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int. J. Mol. Sci, 21.10.3390/ijms21082956 ↗
17. Ishitsuka, Y., Hanaoka, Y., Tanemura, A., and Fujimoto, M. (2021). Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy. Cancers, 13.10.3390/cancers13051148 ↗
18. Mediators of Inflammation in Topical Therapy of Skin Cancers10.1155/2019/8369690 ↗
19. Ursu, R.G., Luchian, I., Ghetu, N., Costan, V.V., Stamatin, O., Palade, O.D., Damian, C., Iancu, L.S., and Porumb-Andrese, E. (2021). Emerging Oncogenic Viruses in Head and Neck Cancers from Romanian Patients. Appl. Sci., 11.10.3390/app11199356 ↗
20. Clinical, histopathological and immunohistochemical study of keratoacanthoma
21. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors10.1111/1346-8138.13390 ↗
22. Intravascular Basal Cell Carcinoma Hiding under a Keratoacanthoma10.1159/000519114 ↗
23. Histogenesis of keratoacanthoma: His-tochemical and immunohistochemical study10.1016/j.oooo.2014.10.006 ↗
24. Keratoacanthoma: A distinct entity?10.1111/exd.12880 ↗
25. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective10.1038/modpathol.2015.5 ↗